Oncogenic osteomalacia: Localization of underlying peripheral tumor with Tc-sestamibi scintigraphy
Arquivos Brasileiros de Endocrinologia e Metabologia, ISSN: 0004-2730, Vol: 52, Issue: 9, Page: 1505-1509
2008
- 6Citations
- 54,839Usage
- 11Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Article Description
Oncogenic osteomalacia is a paraneoplastic syndrome usually induced by bone or soft tissue tumors. It is presented by the development of pain and fractures with hypophosphatemia, hyperphosphaturia, and inappropriate normal/low plasma 1,25(OH) D concentration. After the removal of the tumor the complete resolution of all biochemical and clinical abnormalities is the main characteristic. A case of a 44-year-old female with difficulty in walking due to leg pain and generalized muscle weakness and hypophosphatemia, with relative hyperphosphaturia, is described. A whole-body Tc- sestamibi scintigraphy showed accumulation in the left thigh region, and a small tumor was detected by ultrasound examination. By removal of the tumor, a lipoma, the symptoms improved significantly after a month, with complete recovery by the fourth month. In this case, Tc-sestamibi scintigraphy was useful in identifying the location of the tumor, which caused oncogenic osteomalacia. Copyright© ABE&M.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=60149086186&origin=inward; http://dx.doi.org/10.1590/s0004-27302008000900016; http://www.ncbi.nlm.nih.gov/pubmed/19197461; http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27302008000900016&lng=pt&tlng=pt; http://www.scielo.br/pdf/abem/v52n9/v52n9a16.pdf; http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27302008000900016&lng=en&tlng=en; http://www.scielo.br/scielo.php?script=sci_abstract&pid=S0004-27302008000900016&lng=en&tlng=en; http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27302008000900016; http://www.scielo.br/scielo.php?script=sci_abstract&pid=S0004-27302008000900016; https://dx.doi.org/10.1590/s0004-27302008000900016; https://www.scielo.br/j/abem/a/zd5QqcdQdxZyPS9FVK957HG/?lang=pt
FapUNIFESP (SciELO)
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know